Malignant mesothelioma with heterologous elements: Clinicopathological correlation of 27 cases and literature review

Department of Anatomical Pathology, Flinders University of South Australia, Adelaide, SA, Australia.
Modern Pathology (Impact Factor: 6.19). 07/2008; 21(9):1084-94. DOI: 10.1038/modpathol.2008.125
Source: PubMed


Only a small number of malignant mesotheliomas with heterologous elements have been described. There are currently no criteria for diagnosis and little data regarding prognosis. We suggest that the term heterologous mesothelioma should be reserved for tumours that show malignant heterologous elements, notably osteosarcomatous, chondrosarcomatous, or rhabdomyoblastic elements but have immunohistochemical and clinical characteristics of mesothelioma. We identified 27 such cases and characterized the clinical and pathological characteristics of these tumours. In our series, 89% originated in the pleura, and 11% from the peritoneal cavity. The median age at diagnosis was 68 years, ranging from 27 to 85 years. Of these cases, 93% occurred in males and 7% in women. Of the 27 mesothelioma cases 16 (59%) were sarcomatoid, 10 (37%) were biphasic, and one was reported as epithelioid; 40% (11 cases) showed osteosarcomatous elements only, 19% showed areas of rhabdomyosarcoma only, 19% contained areas of chondrosarcoma only, and 22% exhibited osteochondromatous elements. Immunohistochemical labelling for cytokeratins was present in the majority of cases. Exposure to asbestos was identified in all the 17 cases for which an exposure history was available (63%). Median survival was 6 months after diagnosis, similar to the survival seen in sarcomatoid mesotheliomas. The differential diagnosis includes primary and secondary pleural sarcomas, including osteosarcomas and chondrosarcomas. Immunohistochemical labelling for cytokeratins is helpful in the distinction, but lack of labelling for cytokeratins in a spindle cell/sarcomatoid tumour does not exclude the diagnosis of mesothelioma, irrespective of the presence of heterologous elements. We suggest that if the anatomical distribution conforms to that of mesothelioma, a diagnosis of heterologous mesothelioma should be made in preference to a diagnosis of primary pleural osteosarcoma or chondrosarcoma, regardless of cytokeratin positivity, as for conventional non-heterologous sarcomatoid mesothelioma.

Download full-text


Available from: Douglas W Henderson, Apr 07, 2015
  • Source
    • "Author No. of sarcomatous-type malignant peritoneal mesothelioma Our case 2010 1 Klebe et al. 18 2010 7 Griniatsos et al. 24 2009 1 Baratti et al. 25 2009 1 Kusama et al. 26 2009 1 Klebe et al. 27 2008 2 Hesdorffer et al. 28 2008 4 Zhang and Hao 29 2003 11 Feldman et al. 19 2003 4 Deraco et al. 30 2003 1 Sebbag et al. 31 2000 2 Neumann et al. 32 1999 1 Ros et al. 33 1991 2 "
    [Show abstract] [Hide abstract]
    ABSTRACT: Sarcomatous malignant peritoneal mesothelioma developing in the abdominal cavity is very rare, and little is known about its behavior. A 72-year-old woman was referred to our hospital with anemia and weight loss. Tumor marker levels were within normal limits. Abdominal computed tomography showed an 11¥7 cm tumor in the pelvis, with possible invasion of the large bowel. Colonoscopy revealed a tumor protruding into the cecal lumen with an ulceration of the cecal wall. Although malignancy was suspected, the histological type was not identified in the biopsy specimens. Right hemicolectomy and ileocolic anastomosis were performed as a treatment. A postoperative histopathological examination confirmed the initial diagnosis of malignant mesothelioma. Finally, immunohistochemical examination revealed a localized sarcomatous malignant peritoneal mesothelioma with regional lymph node metastases. The patient was followed up postoperatively as an outpatient, and local recurrence was detected in the abdominal cavity 11 months after surgery. In conclusion, localized malignant peritoneal mesothelioma, especially the sarcomatous type, with large bowel involvement is very rare. We should carefully consider the diagnosis and select adequate therapy, because little is known about the behavior of this disease.
    Full-text · Article · Jul 2010 · Rare tumors
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: A Lorentzian model as the general case of a frequency-dependent behavior of a dispersive dielectric material is considered in this paper. Recursive convolution algorithms for the finite-difference time-domain (FDTD) technique for two cases of a Lorentzian medium, narrowband and wideband, depending on the ratio of a resonance line half-width at -3 dB and the resonance frequency of the material, are detailed. It is shown that a wideband Lorentzian model of a dielectric FR-4 used in printed circuit boards is more flexible and gives good agreement with experimental curves, and may be preferable as compared to a Debye model.
    Full-text · Conference Paper · Sep 2002
  • [Show abstract] [Hide abstract]
    ABSTRACT: Malignant mesothelioma (MM) is an uncommon tumor that can be difficult to diagnose. To develop practical guidelines for the pathologic diagnosis of MM. A pathology panel was convened at the International Mesothelioma Interest Group biennial meeting (October 2006). Pathologists with an interest in the field also contributed after the meeting. There was consensus opinion regarding (1) distinguishing benign from malignant mesothelial proliferations (both epithelioid and spindle cell lesions), (2) cytologic diagnosis of MM, (3) key histologic features of pleural and peritoneal MM, (4) use of histochemical and immunohistochemical stains in the diagnosis and differential diagnosis of MM, (5) differentiating epithelioid MM from various carcinomas (lung, breast, ovarian, and colonic adenocarcinomas and squamous cell and renal cell carcinomas), (6) diagnosis of sarcomatoid mesothelioma, (7) use of molecular markers in the differential diagnosis of MM, (8) electron microscopy in the diagnosis of MM, and (9) some caveats and pitfalls in the diagnosis of MM. Immunohistochemical panels are integral to the diagnosis of MM, but the exact makeup of panels used is dependent on the differential diagnosis and on the antibodies available in a given laboratory. Immunohistochemical panels should contain both positive and negative markers. The International Mesothelioma Interest Group recommends that markers have either sensitivity or specificity greater than 80% for the lesions in question. Interpretation of positivity generally should take into account the localization of the stain (eg, nuclear versus cytoplasmic) and the percentage of cells staining (>10% is suggested for cytoplasmic membranous markers). These guidelines are meant to be a practical reference for the pathologist.
    No preview · Article · Aug 2009 · Archives of pathology & laboratory medicine
Show more